Ingredient or product comparison
AHK-Cu vs Finasteride Mechanism: Research Comparison
The following table compares the primary molecular targets, expected timelines, and research endpoints for AHK-Cu and finasteride in hair follicle biology studies. Each compound operates on a distinct pathway. The purpose of this comparison is to clarify how t
This source-based comparison does not add ratings or recommend a winner.
- The following table compares the primary molecular targets, expected timelines, and research endpoints for AHK-Cu and finasteride in hair follicle biology studies. Each compound operates on a distinct pathway. The purpose of this comparison is to clarify how they differ, not to suggest one replaces the other.
- Primary Molecular Target
- Integrin receptors, lysyl oxidase activation, VEGF upregulation
- Type II 5-alpha reductase enzyme inhibition
- AHK-Cu signals regeneration; finasteride blocks hormonal damage
- Pathway Affected
- Extracellular matrix remodeling, anagen phase extension, dermal papilla vascularization
- DHT synthesis inhibition, androgen receptor signaling reduction
- Complementary pathways. Not overlapping
- Expected Timeline (Experimental Models)
- 8–12 weeks for measurable follicle diameter increase
- 12–16 weeks for hair count stabilization, 24+ weeks for regrowth
- Finasteride acts slower but provides hormonal foundation
- Measurable Research Endpoint
- Hair shaft diameter, dermal papilla cell density, VEGF expression
- DHT levels (serum and scalp), hair count per cm², follicle miniaturization index
- AHK-Cu targets quality; finasteride targets quantity retention
- Limitation Without the Other
- Cannot prevent DHT-driven miniaturization. Regenerative signal overwhelmed by androgen signal
- Cannot repair existing follicle atrophy. Stops damage but doesn't reverse structural loss
- Both required for complete intervention in androgenetic models
- Mechanism Independence
- Works regardless of DHT levels. Purely regenerative
- Works regardless of VEGF or collagen status. Purely hormonal
- Can be combined without pathway interference